Clinical Trial Update: Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 multiple ascending dose trial of miravirsen in treatment-naïve chronic hepatitis C patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Miravirsen (miravirsen)

Snippet

Sponsor: Santaris Pharma A/S | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED